MX2009013086A - Sistema gastrorretentivo con cuerpo de alginato. - Google Patents

Sistema gastrorretentivo con cuerpo de alginato.

Info

Publication number
MX2009013086A
MX2009013086A MX2009013086A MX2009013086A MX2009013086A MX 2009013086 A MX2009013086 A MX 2009013086A MX 2009013086 A MX2009013086 A MX 2009013086A MX 2009013086 A MX2009013086 A MX 2009013086A MX 2009013086 A MX2009013086 A MX 2009013086A
Authority
MX
Mexico
Prior art keywords
gastroretentive system
alginate body
gastroretentive
alginate
release device
Prior art date
Application number
MX2009013086A
Other languages
English (en)
Inventor
Bodo Asmussen
Werner Weitschies
Christiane Schiller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MX2009013086A publication Critical patent/MX2009013086A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención está relacionada con sistemas gastrorretentivos e incluye por lo menos un dispositivo de liberación para por lo menos un principio activo farmacéutico y por lo menos un cuerpo en expansión que está unido al dispositivo de liberación.
MX2009013086A 2007-06-04 2008-05-27 Sistema gastrorretentivo con cuerpo de alginato. MX2009013086A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007026037A DE102007026037A1 (de) 2007-06-04 2007-06-04 Gastroretentives System mit Alginat-Körper
PCT/EP2008/004188 WO2008148478A2 (de) 2007-06-04 2008-05-27 Gastroretentives system mit alginat-körper

Publications (1)

Publication Number Publication Date
MX2009013086A true MX2009013086A (es) 2010-01-18

Family

ID=39942026

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013086A MX2009013086A (es) 2007-06-04 2008-05-27 Sistema gastrorretentivo con cuerpo de alginato.

Country Status (14)

Country Link
US (1) US20100129445A1 (es)
EP (2) EP2497465A3 (es)
JP (1) JP5425058B2 (es)
KR (1) KR101268215B1 (es)
CN (1) CN102215826A (es)
AU (1) AU2008258881B2 (es)
CA (1) CA2689049C (es)
DE (1) DE102007026037A1 (es)
IL (1) IL202518A0 (es)
MX (1) MX2009013086A (es)
NZ (1) NZ581740A (es)
RU (1) RU2468790C2 (es)
WO (1) WO2008148478A2 (es)
ZA (1) ZA200908355B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101118794B1 (ko) * 2009-11-10 2012-06-13 동아제약주식회사 비스포스포네이트를 함유하는 약학 조성물
US9532977B2 (en) 2010-12-16 2017-01-03 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
MX354210B (es) 2010-12-16 2018-02-16 Celgene Corp Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
DE102011051653A1 (de) * 2011-07-07 2013-01-10 Lts Lohmann Therapie-Systeme Ag Quellfähige Manteltablette
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
JP6150896B2 (ja) 2012-08-27 2017-06-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ エタノールの影響に対して耐性を有する胃液抵抗性の医薬組成物又は栄養補助組成物
WO2014032676A1 (en) * 2012-09-03 2014-03-06 S-Biotek Holding Aps A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
EP3091962B1 (en) * 2013-12-05 2022-06-08 Epitomee Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
WO2017083348A1 (en) 2015-11-11 2017-05-18 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CN108721246B (zh) * 2018-05-29 2021-06-25 王喆明 高分子材料构建的多单元超长效口服制剂及其制备方法
US11511093B2 (en) 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
KR102278915B1 (ko) 2019-10-24 2021-07-19 중앙대학교 산학협력단 다공성 하이드로겔을 유효성분으로 함유하는 위 체류 및 약물 방출 제어형 경구용 제제
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
US4816262A (en) 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3803482A1 (de) 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
US4983401A (en) 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
DE69207863T2 (de) 1991-11-13 1996-06-05 Glaxo Canada Vorrichtung zur kontrollierten Wirkstoffreigabe
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
DE4419818C2 (de) 1994-06-07 1998-10-22 Lohmann Therapie Syst Lts Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben
DE4431653C2 (de) 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE19537090A1 (de) 1995-10-05 1997-04-10 Lohmann Therapie Syst Lts Osmotische Vorrichtung zur kontinuierlichen Freisetzung von Wirkstoffen in die Flüssigkeiten des Gastrointestinaltraktes
US20020002364A1 (en) * 1995-10-05 2002-01-03 Karsten Cremer Osmotic device for the continuous release of active compounds into the fluids of the gastrointestinal tract
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US6497902B1 (en) * 1999-12-01 2002-12-24 The Regents Of The University Of Michigan Ionically crosslinked hydrogels with adjustable gelation time
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
HUP0301465A3 (en) 2000-06-23 2006-07-28 Teva Pharma Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
KR20040018394A (ko) 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 위 정체 제어되는 약물 전달 계
US20040219186A1 (en) 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
IN191024B (es) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
AU2003272069A1 (en) 2002-06-26 2004-01-19 Cadila Healthcare Limited Novel floating dosage form
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties

Also Published As

Publication number Publication date
DE102007026037A1 (de) 2008-12-11
JP2010529056A (ja) 2010-08-26
WO2008148478A3 (de) 2009-04-09
EP2497465A3 (de) 2012-11-21
IL202518A0 (en) 2010-06-30
CA2689049C (en) 2014-07-08
JP5425058B2 (ja) 2014-02-26
EP2497465A2 (de) 2012-09-12
AU2008258881B2 (en) 2013-12-19
RU2468790C2 (ru) 2012-12-10
EP2155172A2 (de) 2010-02-24
KR101268215B1 (ko) 2013-05-31
NZ581740A (en) 2011-05-27
WO2008148478A8 (de) 2009-02-05
RU2009147730A (ru) 2011-06-27
ZA200908355B (en) 2010-07-28
CA2689049A1 (en) 2008-12-11
AU2008258881A1 (en) 2008-12-11
CN102215826A (zh) 2011-10-12
KR20100028621A (ko) 2010-03-12
WO2008148478A2 (de) 2008-12-11
US20100129445A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
MX2009013086A (es) Sistema gastrorretentivo con cuerpo de alginato.
EP2313084A4 (en) INTRAUTERINE DISPOSAL SYSTEM FOR PREVENTION
EP2213274A4 (en) DRUG DELIVERY SYSTEM, AND DRUG DELIVERY DEVICE
GB2477046B (en) Devices,systems and methods for medicament delivery
EP1895992A4 (en) PHARMACEUTICAL SYSTEMS COMPRISING COMPRESSIBLE KAUGUMMIBASIS FOR INGREDIENT RELIEF
DK2099434T3 (da) Indretninger og systemer til medikamentindgivelse
EP2111173A4 (en) TREATMENT SYSTEM AND TREATMENT DEVICE
WO2008151299A3 (en) Implantable medical devices for local and regional treatment
MX2009005445A (es) Sistema de suministro para risperidona.
ZA201006144B (en) An intrauterine system
GB2440315B (en) Pressure activated device and breathing system
EP2033569A4 (en) CAPSULE MEDICAL DEVICE AND CAPSULE MEDICAL DEVICE SYSTEM
GB0704709D0 (en) Dispersion, gel and emulsification system
EP2149328A4 (en) CAPTURED MEDICAL DEVICE AND CAPSULATED MEDICAL SYSTEM
EP2088925A4 (en) DYNAMIC POSITIONING SYSTEM OF A PATIENT
GB2478085B (en) Devices, systems and methods for medicament delivery
SG10202001437UA (en) Connection device, connection system and tractor-trailer combination
GB201917148D0 (en) Braking device and braking system
EP2196132A4 (en) CAPSULE MEDICAL DEVICE AND MEDICAL SYSTEM
MX2010008852A (es) Formulaciones de flibanserina.
EP2185133A4 (en) A SYSTEM FOR THE DISPENSING OF MEDICAMENTS IN THE FORM OF CALCIUM PHOSPHATE MICROBALLS AND METHOD FOR THE PRODUCTION THEREOF
EP2189128A4 (en) MEDICAL DEVICE SYSTEM
EP3636511A4 (en) TRAIN AND TRAIN BRAKE RELEASE SYSTEM
IL201689A0 (en) Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles
GB201114400D0 (en) Devices, systems and methods for medicament delivery

Legal Events

Date Code Title Description
FA Abandonment or withdrawal